de Jong D - Search Results

1

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H. Oosten LEM, et al. Among authors: de jong d, de wreede lc. Ann Hematol. 2018 Feb;97(2):255-266. doi: 10.1007/s00277-017-3167-7. Epub 2017 Dec 6. Ann Hematol. 2018. PMID: 29209924 Free PMC article.

2

Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.

Hart A, Baars JW, Kersten MJ, Brandsma D, van Tinteren H, de Jong D, Spiering M, Dewit L, Boogerd W. Hart A, et al. Among authors: de jong d. Neth J Med. 2014 May;72(4):218-23. Neth J Med. 2014. PMID: 24829178 Free article.

3

[Current lymphoma classification: a step forward for pathologists and clinicians].

de Jong D, Kluin PM. de Jong D, et al. Ned Tijdschr Geneeskd. 1997 Aug 16;141(33):1601-13. Ned Tijdschr Geneeskd. 1997. PMID: 9543765 Dutch.

4

Alterations in immunoglobulin genes reveal the origin and evolution of monotypic and bitypic B cell lymphomas.

de Jong D, Voetdijk BM, van Ommen GJ, Kluin PM. de Jong D, et al. Am J Pathol. 1989 Jun;134(6):1233-42. Am J Pathol. 1989. PMID: 2547318 Free PMC article.

5

Oligoclonal development of germinal centre cells as detected by anti-idiotype antibodies.

De Jong D, Cramer G, Brand A, Kluin PM. De Jong D, et al. Scand J Immunol. 1993 May;37(5):602-4. doi: 10.1111/j.1365-3083.1993.tb02578.x. Scand J Immunol. 1993. PMID: 8484106

6

High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.

Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, Hart AA, van Oers MH, van der Hulst M, Baars JW, Bartelink H. Haas RL, et al. Among authors: de jong d. J Clin Oncol. 2003 Jul 1;21(13):2474-80. doi: 10.1200/JCO.2003.09.542. J Clin Oncol. 2003. PMID: 12829665 Clinical Trial.

7

Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.

Baars JW, de Jong D, Willemse EM, Gras L, Dalesio O, v Heerde P, Huygens PC, vd Lelie H, Kr vd Borne AE. Baars JW, et al. Among authors: de jong d. Br J Cancer. 1999 Apr;79(11-12):1770-6. doi: 10.1038/sj.bjc.6690282. Br J Cancer. 1999. PMID: 10206291 Free PMC article.

8

De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis.

Kramer MH, Raghoebier S, Beverstock GC, de Jong D, Kluin PM, Kluin-Nelemans JC. Kramer MH, et al. Among authors: de jong d. Leukemia. 1991 Jun;5(6):473-8. Leukemia. 1991. PMID: 1711639 Review.

9

Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

De Jong D, Voetdijk BM, Beverstock GC, van Ommen GJ, Willemze R, Kluin PM. De Jong D, et al. N Engl J Med. 1988 May 26;318(21):1373-8. doi: 10.1056/NEJM198805263182106. N Engl J Med. 1988. PMID: 3285208 No abstract available.

10

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

Kramer MH, Hermans J, Parker J, Krol AD, Kluin-Nelemans JC, Haak HL, van Groningen K, van Krieken JH, de Jong D, Kluin PM. Kramer MH, et al. Among authors: de jong d. J Clin Oncol. 1996 Jul;14(7):2131-8. doi: 10.1200/JCO.1996.14.7.2131. J Clin Oncol. 1996. PMID: 8683246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters